Cystic fibrosis: comorbidity with other serious diseases
-
Published:2023-07-25
Issue:3
Volume:
Page:98-111
-
ISSN:1682-8658
-
Container-title:Experimental and Clinical Gastroenterology
-
language:
-
Short-container-title:jour
Author:
Yankina G. N.1ORCID, Kondratieva E. I.2ORCID, Loshkova E. V.3ORCID, Doroshenko I. V.1ORCID, Rebrienko M. V.1ORCID, Rafikova Yu. S.1ORCID, Bozhenko E. A.1ORCID, Khavkin A. I.4ORCID, Odinaeva N. D.5ORCID, Zhelev V. A.1ORCID, Liulka T. S.1ORCID, Prudnikova V. K.1ORCID
Affiliation:
1. Siberian state medical University 2. Research Centre for Medical Genetics; Reasearch Clinical Institute of Childhood of the Ministry of Health of the Moscow Region 3. Siberian state medical University; Research Centre for Medical Genetics 4. Research Centre for Medical Genetics; Russian National Research Medical University named after N. I. Pirogov 5. Research Centre for Medical Genetics
Abstract
Numerous epidemiological studies demonstrate that cystic fibrosis, the most common orphan disease in the world, can not occur in isolation, but can be combined with other serious diseases. The most common such combination in all populations is traditionally cystic fibrosis and celiac disease, which, on the one hand, differ in the leading mechanism of inflammation, in cystic fibrosis - chronic microbial inflammation, in celiac disease - autoimmune, on the other hand, these two diseases have a number of common pathogenesis links, in particular, realizing the syndrome of malabsorption, which only complicates the timely diagnosis of these combined pathological conditions. In addition, the authors of the literature review focus on clinical examples of late detection of autoimmune gluten intolerance against the background of cystic fibrosis. They also consider the combination of cystic fibrosis with other severe, disabling diseases (rheumatoid arthritis, phenylketonuria, oncological diseases), which sometimes require a serious change in therapeutic tactics.
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference73 articles.
1. Register of patients with cystic fibrosis in the Russian Federation 2020/ Edited by E. I. Kondratiev, S. A. Krasovsky, M. A. Starinova, A. Yu. Voronkov, E. L. Amelina, N. Yu. Kashirskaya, S. N. Avdeev, S. I. Kutsev . Moscow. ID "MEDPRAKTIKA-M", 2022, 68 p.@@ Registr patsientov s mukovistsidozom v Rossiiskoi Federatsii. 2020 god. / Pod redaktsiei E. I. Kondrat'evoi, S. A. Krasovskogo, M. A. Starinovoi, A. Yu. Voronkovoi, E. L. Amelinoi, N. Yu. Kashirskoi, S. N. Avdeeva, S. I. Kutseva. - M.: ID «MEDPRAKTIKA-M», 2022, 68 s. ISBN 978-5-98803-456-8. 2. Saluzzo F, Riberi L, Messore B, Loré NI, Esposito I, Bignamini E, De Rose V. CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis. Cells. 2022 Apr 6;11(7):1243. doi: 10.3390/cells11071243. PMID: 35406809; PMCID: PMC8998122. 3. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O’Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Erratum in: Lancet Respir Med. 2019 Dec;7(12): e40. PMID: 31570318; PMCID: PMC8862661. 4. Choong E, Sauty A, Koutsokera A, Blanchon S, André P, Decosterd L. Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now? Pharmaceutics. 2022 Aug 11;14(8):1674. doi: 10.3390/pharmaceutics14081674. PMID: 36015300; PMCID: PMC9412421. 5. Gavillet H, Hatfield L, Rivett D, Jones A, Maitra A, Horsley A, van der Gast C. Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis. Microbiol Spectr. 2022 Oct 26;10(5): e0041922. doi: 10.1128/spectrum.00419-22. Epub 2022 Aug 16. PMID: 35972283; PMCID: PMC9602735.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|